Related Experiment Videos

High-dose therapy for aggressive non-Hodgkin's lymphoma

¹Department of Cellular and Molecular Sciences, St George's Hospital Medical School, London.

British Journal of Hospital Medicine

|November 10, 1996

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Durable benefit of rituximab maintenance post-autograft in patients with relapsed follicular lymphoma: 12-year follow-up of the EBMT lymphoma working party Lym1 trial.

Bone marrow transplantation·2021

Relaxation versus exercise for improved quality of life in lymphoma survivors-a randomised controlled trial.

Journal of cancer survivorship : research and practice·2020

Favourable outcomes for high-risk diffuse large B-cell lymphoma (IPI 3-5) treated with front-line R-CODOX-M/R-IVAC chemotherapy: results of a phase 2 UK NCRI trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2020

Lymphoma survivors' experience of participation in a home-based intervention post-chemotherapy.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2019

Trends in incidence and medical resource utilisation in patients with chronic lymphocytic leukaemia: insights from the UK Clinical Practice Research Datalink (CPRD).

Annals of hematology·2014

Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel.

Breast cancer research and treatment·2014

See all related articles